This site is intended for Healthcare professionals only.

Lupin gets USFDA approval for generic malaria drug

Lupin gets USFDA approval for generic malaria drug

New Delhi: Drug firm Lupin said it has received approval from the US health regulator for Hydroxychloroquine Sulfate tablets, which is used to treat malaria.

The company has received final approval from the USFDA for its product, which is a generic version of Concordia Pharmaceuticals, Inc’s Plaquenil tablets, Lupin said in a statement.

The drug is indicated for the treatment of malaria and acute and chronic rheumatoid arthritis in adults.

According to IQVIA MAT April 2018 data, Hydroxychloroquine Sulfate tablets had annual sales of around $215.3 million in the US.

The following two tabs change content below.
Ruby Khatun

Ruby Khatun

Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at Contact no. 011-43720751

Source: PTI
0 comment(s) on Lupin gets USFDA approval for generic malaria drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted